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It remains unclear if quality of life (QoL) improvements could be expected in young 
patients after malignant bone tumour surgery after 2 years. To assess the course of 
QoL over time during a long- term follow- up, malignant bone tumour survivors of a 
previous short- term study were included. Assessments were done at least 5 years 
after surgery. QoL was measured with Short- form (SF)- 36, TNO- AZL Questionnaire 
for Adult’s Quality of Life (TAAQOL) and Bone tumour (Bt)- DUX. QoL throughout the 
follow- up was analysed by linear mixed model analysis. From the original cohort of 44 
patients; 20 patients were included for this study, 10 males; mean age at surgery 
15.1 years and mean follow- up 7.2 years. Twenty- one patients of the initial cohort 
(47%) deceased. Fifteen patients (75%) underwent limb- salvage and five (25%) abla-
tive surgery. QoL improved significantly during follow- up at Physical Component 
Summary Scale scale of the SF- 36 and TAAQOL and all subscales of the Bt- DUX 
(p < .01). No significant differences were found between current evaluations and pre-
vious evaluations at 2 years after surgery (p = .41–.98). Significant advantages after 
limb- salvage were seen at the PCS scale of the SF- 36 (MD 13.7, p = .05) and the cos-
metic scale of the Bt- DUX (MD 17.7, p = .04).
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1  | INTRODUCTION
Malignant bone tumours, especially osteosarcoma and Ewing sar-
coma account for approximately 6% of all cancers in children younger 
than 20 years of age (Damron, Ward, & Stewart, 2007; Steliarova- 
Foucher et al., 2004; Stiller, Bielack, Jundt, & Steliarova- Foucher, 
2006). Both bone malignancies have a preference for origination in 
the metaphysical region of long bones; particularly the knee region 
(Damron et al., 2007). Since the 1970s, 5 years survival rates in pa-
tients with bone sarcoma have increased significantly from less than 
20% to 60%–70%; striking changes in surgery for bone tumours ac-
companied this change in survival due to chemotherapy improve-
ments (Steliarova- Foucher et al., 2004; Stiller et al., 2006). Whereas 
in the late 1970s amputation was needed in three- quarter of patients, 
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due to a combination of improved imaging modalities, nowadays sur-
gical techniques and the responsiveness to chemotherapy led to 85% 
or more of the patients to limb- salvage (Abed & Grimer, 2010; Grimer, 
2005; Wafa & Grimer, 2006).
Although a few reports on quality of life (QoL) are published, 
most of these studies report QoL levels at one single time point 
in a wide range of years after surgery and therefore lack informa-
tion about the duration and extent of the recovery (Eiser & Grimer, 
1999; Nagarajan, Neglia, Clohisy, & Robison, 2002). Furthermore, 
only a few studies presented longitudinal assessments of QoL 
after malignant bone tumour surgery. Limitations of these longitu-
dinal studies were the inclusion of patients with tumour sites in 
the upper extremity or trunk in addition to patients with tumour 
sites in the lower extremity. Lower extremity or trunk tumours are 
less common and have different functional and emotional conse-
quences. Other limitations were a short follow- up period or a con-
fined number of evaluations (Frances, Morris, Arkader, Nikolic, & 
Healey, 2007; Han, Wang, & Bi, 2012; Hinds et al., 2009; Koopman 
et al., 2005; Liu et al., 2014). Therefore, we evaluated a few years 
ago QoL levels at six time points of a cohort of children and adoles-
cents under the age of 25 after malignant bone tumour surgery of 
the lower limb. In this previous study, improvements of QoL levels 
were reported from surgery up to 24 months thereafter and were 
most pronounced and significant over the first year after the sur-
gery. Over the second year improvements became smaller and the 
differences between QoL scores at 1 and 2 years after surgery were 
mostly non- significant (Bekkering, Vliet Vlieland, Koopman, et al., 
2012). However, QoL scores still differed from scores of healthy 
peers and it remains unclear if further improvements could be ex-
pected after this period. Therefore, the aim of this study was to 
assess the course of QoL over time between 2 and 5 years or more 
after surgery.
2  | MATERIALS AND METHODS
2.1 | Study design and patient recruitment
The study had a prospective and multi- centre design. All consecu-
tive patients who underwent a surgical intervention due to a bone 
sarcoma around the knee joint in one of three university medical cen-
tres in the Netherlands (Leiden University Medical Centre, Academic 
Medical Center University of Amsterdam and Erasmus University 
Medical Centre – Sophia Children’s Hospital Rotterdam) between 
January 2004 and January 2008 were invited by their oncologist or 
orthopaedic surgeon to participate in the previous study. Patients 
were eligible if they were aged between 8 and 25 years at the time 
of surgery, the bone sarcoma (osteosarcoma or Ewing sarcoma) was 
located around the knee and the surgical intervention consisted of 
limb- salvage or ablative surgery. Patients were excluded if medical 
conditions other than bone tumour surgery limited their physical 
activities. At long- term follow- up (more than 5 years after surgery), 
all survivors of the original study cohort were invited to participate 
in this study. The Medical Ethics Committee of all three centres 
approved the extension of the study and all patients signed the in-
formed consent.
2.2 | Assessment methods
Assessments included; questionnaires concerning QoL which were 
sent by post and an interview with the investigators (PB and JvE). 
Patients’ baseline socio- demographic (Table 1) and clinical character-
istics (age, gender, morphology and the type of surgical intervention) 
as well as orthopaedic or oncological complications occurring during 
the follow- up (lung metastases, local recurrence, endoprosthetic or 
allograft failure, stump infection and type of surgical treatment) were 
derived from the medical record. Failures of limb- salvage after re-
constructive surgery for bone tumours were classified according to 
Henderson et al. (2014).
Information about the highest level of education, work, mar-
ital or family status, sportive activities and sportive and/or social 
limitations were obtained during a structured interview with the 
investigators.
2.3 | Quality of life
The Short Form (SF)- 36 is a generic QoL measure, evaluating eight 
health concept scales; physical functioning, physical role limitation, 
bodily pain, general perception of health, vitality, social function, emo-
tional role limitation and mental health. Each scale score ranges from 
0 (worst health state) to 100 (best health state). These eight scales can 
be converted into a Physical Component Summary Scale (SF36- PCS) 
and a Mental Component Summary scale (SF36- MCS). Scores above 
and below the mean score 50 (standard deviation SD = 10) indicating 
above and below average QoL respectively (Aaronson et al., 1998; 
Ware et al., 1995, 1998).
The age specific TNO- AZL Questionnaire for Adult’s Quality of 
Life (TAAQOL) for persons of 16 years and older consist of 12 health 
concept scales: gross motor functioning, fine motor functioning, cog-
nition, sleep, pain, social contacts, daily activities, sex, vitality, happi-
ness, depressive mood and anger (Kamphuis et al., 2002) The domain 
scores of the TAAQOL can be converted into a Mental Component 
Summary Scale (TAAQOL- MCS) and a Physical Component Summary 
Scale (TAAQOL- PCS) (Bekkering, Vliet Vlieland, Koopman, et al., 
2012; Maurice- Stam, Grootenhuis, Caron, & Last, 2007; Maurice- 
Stam et al., 2008; Ware et al., 1995). Scores above and below the 
mean score of 50 (SD = 10) indicating above and below average QoL 
respectively. In patients younger than 16 years during the initial study 
the Mental and Physical Component Summary scale scores of the 
TNO- AZL Children’s Quality of Life questionnaire (TACQOL) were 
used (Verrips, Vogels, den Ouden, Paneth, & Verloove- Vanhorick, 
2000; Vogels et al., 1998).
The Bone tumour (Bt)- DUX is a disease specific questionnaire for 
QoL assessment in patients after malignant bone cancer surgery of the 
leg (Bekkering et al., 2009; Bekkering et al. 2013) comprising 20 items 
within four domains (social, emotional, cosmetically and physical). The 
scoring of the items is done by abstract faces with varying expressions, 
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ranging from very happy (score 1) to sad (score 5). The raw item scores 
are converted into total and domain scores, ranging from 0 to 100, 
with the highest scores indicating better QoL.
2.4 | Statistical analysis
All analyses were performed with IBm-spss statistics 20.0 for Windows 
(SPSS Inc., Chicago, IL, USA). To analyse QoL levels over time a linear 
mixed model was used, with subject as random variable. Estimated 
marginal means with their corresponding standard errors are com-
puted at each time point for the two groups of patients: ablative limb 
and salvage surgery, as well as for the full sample. The level of signifi-
cance was set at p < .05 in all statistical analysis.
3  | RESULTS
3.1 | Patients
Twenty patients from the original cohort of 44 patients were included 
for reassessment at more than 5 years after surgery (mean 7.2 years, 
range 5.1–8.8 years) for this study. Ten of them were males and 10 
females, mean age at surgery was 15.1 years (SD 3.9), age at last eval-
uation was 22.3 years (SD 4.0) and follow- up duration was 7.2 years 
(SD 1.1). Fifteen patients (75%) underwent limb- salvage and 5 (25%) 
ablative surgery. All patients were treated conform EURAMOS- , 
EORTC/EOI- 80931 or Euro- EWING protocol.
The loss of patients during the study is shown in Figure 1. Twenty- 
one patients of the original cohort died of disease (DOD) and one 
patient was excluded for social/emotional problems before the cur-
rent evaluation started. From the remaining 22 patients; two patients 
refused for unknown reasons to participate in the extension of the 
study. The 5 years survival of our cohort was 55%. More patients died 
within 5 years in the ablative surgery group (69% against 37% in the 
limb- salvage group), osteosarcoma patients (62% against 0% in Ewing 
sarcoma patients) and in patients with in the distal femur localised 
bone tumours (66% against 25% in the proximal tibia). The Kaplan–
Meier survival curve of our 44 children and adolescents after limb- 
salvage and ablative surgery is shown at Figure 2.
From the 20 patients who survived and agreed to participate in 
this study, one patient had progression of disease during the 5 years 
follow- up (alive with disease AWD) and was treated several times with 
thoracic surgery due to lung metastases.
TABLE  1 Socio- demographic and disease characteristics of all patients in study and patients who completed the full study
All patients (N = 44) Limb- salvage (N = 27) Ablative surgery (N = 17)
Long- term 
follow- up (N = 20)
Gender, N (%)
Female 17 (39) 9 (33) 8 (47) 10 (50)
Male 27 (61) 18 (67) 9 (53) 10 (50)
Age at surgery, years (SD) 14.9 (4.8) 15.1 (5.1) 14.5 (4.4) 15.1 (3.9)
Age at last evaluation, years (SD) 22.3 (4.0)
Duration follow- up, years (SD) 7.2 (1.1)
Type of surgery, N (%)
Allograft 8 (18) 6 (30)
Prosthesis 19 (43) 9 (45)
Amputation 10 (20) 5 (25)
Rotationplasty 7 (16) 0 (0)
Morphology, N (%)
Osteosarcoma 39 (89) 25 (85) 16 (94) 15 (75)
Ewing’s sarcoma 5 (11) 4 (15) 1 (6) 5 (25)
Localisation, N (%)
Distal femur 32 (73) 20 (74) 12 (70) 11 (55)
Proximal tibia 12 (27) 7 (26) 5 (30) 9 (45)
Progression of disease, N (%)
Lung metastases at diagnosis 8 (18) 5 (19) 3 (18) 0 (0)
Lung metastases during follow- up 24 (55) 11 (41) 13 (77) 1 (5)
Local recurrence 10 (23) 7 (26) 3 (18) 0 (0)
Health status at last follow- up, N (%)
Dead of disease (DOD) 21 (47) 10 (37) 11 (65)
Alive with disease (AWD) 1 (2) 1 (6) 1 (5)
No evidence of disease (NED) 22 (55) 17 (63) 5 (29) 19 (95)
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Surgery- related complications were quite common among our sur-
vivors, among the limb- salvage patients 67% and in ablative surgery 
20% encountered complications. However, these differences were not 
significant according to the Fisher’s Exact Test. Three patients with an 
allograft (50%) encountered problems; one due to a delayed graft- host 
union (type 2 failure according to Henderson), one due to fracture of 
the allograft (type 3) and one due to infection (type 4). Seven patients 
with an endoprosthesis (78%) encountered problems; two due to 
aseptic loosening (type 2 failure), four due to structural failure (type 
3) resulting into prosthesis revision and one due to infection (type 4) 
(Henderson et al., 2014). One amputation patient (20%) encountered 
problems due to stump infection.
At long- term follow- up, 19 of the remaining patients (95%) were 
active with study, job or both, one patient was full- time mother.
The educational level of 11 (55%) of our patients has been 
low (up to and including lower technical and vocational training); 
medium (up to and including secondary technical and vocational 
training) in seven (35%) patients; and high (up to and including 
higher technical and vocational training and university) in two (10%) 
patients.
Four (20%) of our patients reported limitations in work or study 
due to the surgical intervention, seven patients (35%) reported social 
limitations and 10 patients (50%) reported limitations in their sportive 
F IGURE  2 Kaplan–Meier survival curve for children and 
adolescents after limb- salvage and ablative surgery
TABLE  2 Estimated marginal mean scores (standard error in 
brackets) and differences between evaluations at 2 years after 
surgery versus long- term (more than 5 years) follow- up
2 years Long- term Mean difference (CI) p
SF- 36
PCS 42.3 (3.1) 39.2 (3.1) 3.1 (−4.4 to 10.6) .41
MCS 56.6 (2.3) 57.5 (2.3) −0.9 (−6.3 to 4.4) .74
TAAQOL
PCS 43.8 (4.1) 42.3 (3.2) 1.5 (−5.5 to 8.4) .68
MCS 52.3 (2.1) 50.6 (2.3) 1.7 (−2.9 to 6.2) .47
Bt- DUX
Emotional 79.9 (3.4) 77.5 (3.6) 2.3 (−5.9 to 10.5) .57
Social 82.8 (3.5) 83.2 (3.7) −0.3 (−8.9 to 8.2) .94
Cosmetic 77.7 (3.5) 77.3 (3.7) −0.1 (−10.5 to 10.2) .98
Physical 57.3 (4.3) 57.4 (4.6) −0.1 (−10.5 to 10.2) .98
Total 74.4 (2.9) 73.8 (3.2) 0.6 (−6.6 to 7.9) .86
PCS, Physical component summary score; MCS, Mental component sum-
mary score; CI, 95% Confidence interval.
F IGURE  1 Flow chart; showing the number of patients in the 
study and those who dropped out at different stages of the study
3 months
Still in study N = 41
Completed evaluation N = 34
Inclusion
N = 44
6 months
Still in study N = 39
Completed evaluation N = 30
9 months
Still in study N = 34
Completed evaluation N = 27
12 months
Still in study N = 33
Completed evaluation N = 26
24 months
Still in study N = 24
Completed evaluation N = 24
18 months
Still in study N = 27
Completed evaluation N = 23
2 patients dropped out
(DOD)
5 patients dropped out
(DOD)
3 patients dropped out
(DOD)
6 patients dropped out
(DOD)
1 patient dropped out
(DOD)
3 patients dropped out
2 died of disease (DOD) and 1
for social/emotional problems
Long term follow-up
(mean 7.2 years)
N = 20
4 patients dropped out
2 DOD and 2 refused to
participate in the extended
study
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abilities. Eleven patients (55%) were active in sports, mainly individual 
and all low intensive sports like fitness, swimming or biking (7 patients 
choose another sport due to the surgery). Eleven patients (55%) were 
still living with their parents; 10 were involved in a relationship and 
four had one or more children.
3.2 | Long- term versus short- term follow- up
Table 2 displays the estimated marginal mean QoL scores and the 
differences between the short- time evaluation at 24 months and 
the long- term evaluation at a minimum of 5 years after surgery. 
Differences between the QoL measures at long- term follow- up and 
the previous measurement at 24 months since surgery were very 
small and not significant.
3.3 | Limb- salvage versus ablative surgery
Table 3 displays the estimated marginal mean QoL scores and the 
differences between patients after limb- salvage and ablative sur-
gery. Patients after limb- salvage surgery scored predominantly 
better than patients after ablative surgery, these differences were 
significant for the PCS of the SF36 and the cosmetic scale of the 
Bt- DUX.
3.4 | Course over time since surgery
Table 4 and Figure 3 displays the changes over time since surgery. 
The Estimated Marginal Mean scores of the PCS of SF- 36 and 
TAAQOL and all Bt- DUX scores improved significantly over time 
since surgery as evaluated with a Linear Mixed Model analyses. 
However, these improvements were most pronounced during the 
first year after the surgery, levelled off during the second year and 
were nearly absent between follow- up at 24 months and the follow-
 up in this study.
During follow- up, the SF- 36 and TAAQOL Mental Component 
Summary scale (MCS) scores from our patients were consistently 
above the mean of their healthy peers; however, these differences 
were non- significant.
3.5 | Course over time for the different surgical  
groups
Table 4 report the changes over time since surgery for the differ-
ent surgery groups separately. Estimated Marginal Mean scores var-
ied strongly over time since surgery and among all QoL subscales. 
However, the differences between the surgery groups were not 
significant.
4  | DISCUSSION
This article reports the results of a reassessment of QoL levels of a 
prospective cohort of bone sarcoma patients long- term after surgery 
of the leg.
Due to DOD only half of the original cohort of 44 patients could 
be invited for this extended study, limiting the generalisability of the 
results of this study. The 5 years survival rate of 55% in our study 
is comparable with other studies among young patients after lower 
extremity bone tumours (Bacci et al., 2006; Damron et al., 2007; 
Hagleitner et al., 2011).
During the 5 years follow- up, patients after endoprosthetic re-
placement encountered more surgery- related complications than 
patients after ablative surgery. Besides endoprosthetic failures like in-
fection or loosening were structural failures of the endoprosthesis the 
most frequent failures within the follow- up period, and compared with 
other studies reporting an estimated 5- and 8-year implant survival 
rates of 68% and 58% respectively (Capanna et al., 2015; Pala et al., 
2013). However, our study consists of a small cohort of predominantly 
Limb- salvage (N = 15) Ablative surgery (N = 5) Mean difference (CI) p
SF- 36
PCS 43.0 (3.5) 29.3 (5.9) 13.7 (0.2–27.2) .05*
MCS 56.7 (2.8) 60.0 (4.5) −3.0 (−13.4 to 7.4) .74
TAAQOL
PCS 43.9 (3.9) 35.4 (6.1) 8.5 (−5.8 to 22.8) .24
MCS 49.7 (2.8) 53.2 (4.2) −3.5 (−13.5 to 6.5) .49
Bt- DUX
Emotional 79.7 (4.3) 72.5 (6.9) 7.1 (−8.8 to 23.1) .38
Social 85.3 (4.3) 75.9 (7.1) 9.4 (−6.9 to 25.8) .26
Cosmetic 81.2 (4.4) 63.4 (7.1) 17.7 (1.3–34.2) .04*
Physical 56.2 (5.3) 55.9 (8.7) 0.4 (−19.8 to 20.6) .97
Total 75.9 (3.8) 66.7 (6.1) 9.2 (−5.1 to 23.5) .21
PCS, Physical component summary score; MCS, Mental component summary score; CI, 95% confi-
dence interval.
*Significant at the .05 level.
TABLE  3 Estimated marginal mean 
scores (standard error in brackets) and 
differences between limb- salvage versus 
ablative surgery patients at more than 
5 years follow- up
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young patients, possibly loading their endoprosthesis more intensively 
as elderly patients in other studies by working, studying or leisure 
activities.
In comparison with healthy peers, our patients report signifi-
cantly lower QoL scores regarding the physical QoL domains and 
advantageous scores at the mental QoL domains. These findings are 
in line with previous studies among patients with bone sarcoma of 
the leg that consistently demonstrated lower QoL scores within do-
mains associated with physical functioning and similar scores within 
domains associated with mental functioning in patients as compared 
to healthy peers (Eiser, Darlington, Stride, & Grimer, 2001; Eiser & 
Grimer, 1999; Hoffman, Saltzman, & Buckwalter, 2002; Koopman 
et al., 2005; Rodl et al., 2001; Veenstra, Sprangers, van der Eyken, & 
Taminiau, 2000).
It is assumed that the response shift phenomenon plays a role in 
these positive mental QoL outcome scores. Response shift is defined 
as a change in the self- report as a result of: a change in internal stan-
dards (recalibration), a change in values (reprioritisation) or a change 
in the sense of QoL itself (reconceptualisation). Response shifts may 
be seen as a desirable result of the ability of humans confronted with 
a life- threatening or chronic disease to adapt to changing circum-
stances to make life bearable (Breetvelt & van Dam, 1991; Jansen, 
Stiggelbout, Nooij, Noordijk, & Kievit, 2000). The mental QoL sta-
tus of our patients remained favourable in comparison with healthy 
peers from the first evaluation at 3 months after surgery until the 
last evaluation with absence of deterioration due to normalisation 
or the experience of functional limitations and surgery- related 
complications.
Differences in QoL scores of patients after limb- salvage and ablative 
surgery are small and are predominantly non- significantly different from 
each other. These results are in line with previous studies reporting small 
and inconsistent differences between the surgery groups. Some of these 
TABLE  4 Estimated marginal mean scores (standard error) of quality of life measures and difference over time for the whole group and 
between the surgery groups
Time points (months) p- value
3 6 9 12 18 24 60+
CS CS*surgeryN = 34 N = 30 N = 27 N = 26 N = 23 N = 24 N = 20
SF-36
PCS
ALL 10.1 (2.7) 17.0 (2.6) 29.4 (2.8) 34.2 (2.7) 35.9 (3.1) 42.3 (3.1) 39.2 (3.1) <.001* .09
LS 15.8 (3.6) 17.1 (3.3) 28.4 (3.5) 37.8 (3.4) 34.8 (3.9) 43.8 (3.8) 43.0 (3.5)
AS 3.4 (4.0) 17.1 (4.0) 31.5 (4.5) 28.6 (4.3) 37.2 (4.3) 40.0 (5.0) 29.3 (5.9)
MCS
ALL 56.7 (2.1) 61.0 (2.0) 59.9 (2.1) 58.4 (2.1) 57.2 (2.2) 56.6 (2.3) 57.5 (2.3 .45 .71
LS 57.0 (2.8) 59.4 (2.6) 59.7 (2.8) 56.8 (2.7) 59.0 (3.0) 55.8 (2.9) 56.7 (2.8)
AS 56.7 (3.1) 63.3 (3.1) 60.4 (3.5) 60.9 (3.4) 55.1 (3.4) 58.1(3.9) 59.7 (4.5)
TAAQOL
PCS
ALL 11.5 (2.7) 22.9 (2.8) 30.1 (2.9) 38.6 (2.8) 42.9 (3.0) 43.8 (4.1) 42.3 (3.2) <.001* .25
LS 11.2 (3.6) 17.9 (3.7) 29.8 (3.9) 37.6 (3.7) 41.6 (4.1) 43.8 (3.8) 43.9 (3.9)
AS 12.2 (4.2) 29.3 (4.2) 30.7 (4.4) 40.0 (4.4) 44.5 (4.5) 43.3 (4.9) 35.4 (6.1)
MCS
ALL 48.5 (1.9) 53.1 (2.0) 51.3 (2.1) 53.3 (2.0) 53.6 (2.1) 52.3 (2.1) 50.6 (2.3) .5 .51
LS 50.2 (2.6) 51.5 (2.7) 51.5 (2.8) 53.3 (2.7) 54.1 (2.9) 51.1 49.7 (2.8)
AS 46.4 (2.7) 54.9 (3.0) 51.2 (3.2) 53.1 (3.2) 53.0 (3.2) 54.5 (3.5) 53.2 (4.2)
Bt- DUX
Total
ALL 60.9 (2.6) 63.1 (2.7) 69.9 (2.9) 68.6 (2.9) 74.4 (3.1) 74.4 (2.9) 73.8 (3.2) <.001* .19
LS 63.1 (3.5) 60.1 (3.6) 66.8 (3.7) 67.5 (3.7) 75.0 (4.0) 74.9 (3.8) 75.9 (3.8)
AS 58.2 (4.2) 66.6 (4.1) 74.4 (4.5) 74.4 (4.5) 73.2 (4.8) 73.4 (5.1) 66.7 (6.1)
PCS, Physical component summary score; MCS, Mental component summary score; ALL, All patients; LS, Limb- salvage; AS, Ablative surgery; 60+, long- 
term follow- up at more than 5 years after surgery; CS, Change score (linearly independent pair wise comparisons among the estimated marginal means); 
CS*surgery, Change score in relation to the different surgical interventions (linearly independent pair wise comparisons among the estimated marginal 
means).
*Significant at the .05 level.
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studies report advantages in favour of the ablative surgery patients and 
some in favour of the limb- salvage patients. However, these differ-
ences are small, limited to subscales of QoL measures and mostly not 
significant (Akahane et al., 2007; Aksnes et al., 2008; Bekkering, Vliet 
Vlieland, Fiocco, et al., 2012; Eiser et al., 2001; Ginsberg et al., 2007; 
Hopyan, Tan, Graham, & Torode, 2006; Nagarajan et al., 2002; Zahlten- 
Hinguranage, Bernd, Ewerbeck, & Sabo, 2004; Zahlten- Hinguranage, 
Bernd, & Sabo, 2003). In this study, however, at two subscales: the PCS 
of the SF- 36 and the cosmetic scale of the Bt- DUX, patients after abla-
tive surgery scored significantly lower than after limb- salvage, indicating 
that patients after ablative surgery appear to be less content with the 
functional and cosmetic results of the surgery.
The course over time of QoL scores was comparable for both sur-
gical intervention groups with only small and dissimilar differences at 
the different time points. These findings are in contradiction with our 
clinical experience and expert findings seeing a fast recovery and ac-
tive lifestyle in ablative surgery patients and a longer rehabilitation 
and sedentary lifestyle in limb- salvage patients. However, as reported 
earlier, our study consists of a small number of patients.
As reported in the initial study; Physical QoL levels improved sig-
nificantly during a 2 year follow- up after surgery. However, these im-
provements were mainly achieved in the first year after surgery and 
appeared to be small in the second year (Bekkering, Vliet Vlieland, 
Koopman, et al., 2012). With this extended study we aimed to de-
termine if between the last evaluation at 2 years after surgery and 
this long- term follow- up evaluation further QoL improvements were 
achieved. During the reported interval, nearly all QoL scores appeared 
to have been declined. On the basis of these results, we could con-
clude that in children and adolescents after bone sarcoma surgery 
around the knee, no further improvements in QoL levels could be 
expected after 2 years. The results of previous studies on QoL after 
bone sarcoma surgery support this conclusion and report comparable 
QoL scores at their evaluations with a longer follow- up duration (Eiser, 
2009; Ginsberg et al., 2007; Hopyan et al., 2006; Koopman et al., 
2005).
Despite functional disability, progressive disease and surgical re- 
interventions, our survivors after paediatric bone cancer are busy with 
work, study, relationships, and sometimes they have founded a family. 
Apparently, these functional constraints are no limitation to age ap-
propriate social participation. It is therefore recommendable, to use in 
research among long- term primary bone cancer survivors a measure 
instrument within the World Health Organization classification do-
main participation; such as the Reintegration into Normal Living (RNL) 
index (Nagarajan et al., 2003). Furthermore, since malignant bone 
tumours patients after a follow- up of 5 years from surgery still score 
significantly lower on the physical QoL aspects than healthy peers, it’s 
interesting to know if by intensive or specific training programs better 
outcome could be achieved.
The small number and young age of the survivors in our study limit 
the generalisability of the results. Therefore, prospective studies with 
a larger cohort of bone tumour patients with a wider age range are 
needed. However, despite these limitations this study is the first to 
prospectively examine QoL of survivors of childhood or adolescent 
malignant bone cancer and included a long- term prospective design.
In conclusion, at long- term follow- up, no further QoL improve-
ments were achieved in comparison with the 2 years follow- up. 
Course and outcome of QoL scores after the different surgical inter-
ventions were generally comparable, however, they were significantly 
inferior for patients after ablative surgery at the physical (SF- 36) and 
cosmetic domains.
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